Abstract:
Intravenous laser and non-laser light-emitting diode (LED) implant having the capacity to be fitted with a plurality of numerous separate nanometers of laser or non-laser light, attached radially in an inwardly-facing, saline-filled inflatable ring where LEDs are ran in sequence on separate contact tracks that are attached to a dual-strand cord, which leads to a component containment compartment housing certain electronic components, remote signal receiver, and a battery. A preferred embodiment includes the inflatable ring of LEDs, surgically inserted into a human vein by-way of catheter, inflated by syringe with a saline solution, to provide irradiation of cancerous cells or viruses incorporated with circulated blood, activated by a hand-held remote control.

Description:
STATEMENT OF FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT 
       [0001]    Not Applicable 
       DESCRIPTION OF APPENDIX 
       [0002]    Not Applicable 
       BACKGROUND OF THE INVENTION 
       [0003]    This invention relates generally to the field of implantable medical devices, and more specifically to an intravenous, light-radiating implant, activated by a remote control. 
         [0004]    Numerous of established medically and scientifically sound applications of specific nanometers of visible and invisible laser and non-laser light have been utilized in the process of destroying cancerous human cells, and an assortment of viral and bacterial infestations. 
         [0005]    Some of the applications of light were incorporated with light-sensitizing dyes or contrast agents introduced into targeted malign cells, rendering these cells vulnerable to subjection to exposure to collimated beams of light. When these light-absorbent chemicals are struck by these beams, the chemicals break apart into substances that destroy the targeted cells. Another application utilizes a low-power pulsating laser that requires no sensitizing chemicals to create vulnerability, but rather utilizes visible violet light at the 425 nanometer range of the spectrum. This “excitation” laser creates a vibration significant to rupture the capsid or “shell” which envelopes viral DNA or RNA (genetic material), rendering the virus unable to enter a human lymphocite cell where it would ordinarily commandeer the lymphocite&#39;s genetic material to replicate itself. Pulsation of this collimated beam of violet light provides a cooling-off period which protects blood cells within close proximity to targeted viruses. 
         [0006]    Yet another application of light involves the introduction of psoralens, taken orally, that enter the circulatory system to intermingle with blood components. Though otherwise innocuous, these microscopic compounds become active molecular surgeons that serve to chip away chemical links that bind the DNA molecules of the cells involved in lymphomatic leukemia and T-cell lymphoma, when blood is exposed to wider-range waves of invisible ultraviolet light. 
         [0007]    In all cases of exposure to light to decrease the number of targeted cells, blood is pumped out of the patient&#39;s body through clear tubes where it then passes through specific nanometers of laser or non-laser light and is reintroduced back into the patient&#39;s body. There are, however, extremely detrimental side effects associated with the continuous routing of blood from and back into the body. Blood removed multiple times from its natural habitat begins to separate or disintegrate. This condition is called hemolysis and can even prove fatal at times. And because viral cells also tend to infest non-blood tissue, discontinuation of out-of-body routing would result in rapid reinfestation of viruses into the circulatory system. The need for a method and device to take the light to the blood in a practical and effective manner resulted in the process and invention herein. 
       BRIEF SUMMARY OF THE INVENTION 
       [0008]    The primary object of the invention is to provide a multiple-spectrum, laser or non-laser, non-pharmaceutical, intravenous implant that, through its application, destroys genetic material that is instrumental in the process of replication of certain viral cells. 
         [0009]    Another object of the invention is to provide a means through which to remotely-activate a photodynamic process of destroying blood borne cancer cells, in a time-predictable manner, after the introduction of a contrast agent sensitizes the targeted malign cells. 
         [0010]    Another object of the invention is to provide a means through which to expose human blood to specific nanometers of light without the necessity of removing the blood from the patient&#39;s body. 
         [0011]    A further object of the invention is to provide a process through which the elimination of blood borne human immunodeficiency virus and numerous of other viral infestations may be affected without the detrimental side effects associated with many antiviral pharmaceuticals. 
         [0012]    Other objects and advantages include the conformation of the circumference of the invention to accommodate the inner perimeter of the selected vein, on the inside of the upper-thigh. The invention is designed to be “adjustable”, reducing the number of LEDs in a larger model and utilizing a number sufficient for a smaller circle. 
         [0013]    Still another object of the invention is to provide an in-vein light “filter” that would remain activated to constantly maintain viral load at an immeasurable level to afford a human body&#39;s own immune-response mechanism to produce antibodies sufficient to combat viral cells in non-blood tissue, using total-surface light-emitting diodes in the purple portion of the visible light spectrum in the form of a very low power femtosecond laser system. 
         [0014]    Further objects and advantages of the present invention will become apparent from the following descriptions, taken in conjunction with accompanying drawings, wherein, by way of example and illustration, an embodiment of the present invention is disclosed. 
         [0015]    In accordance with a preferred embodiment of the invention, there is disclosed Intravenous Laser/Non-Laser Light-Emitting Diode Implant For Destroying Blood Borne Viral Infestations And Other Malign Cells Integrated Among Blood Components In A Human Circulatory System comprising: a plurality of select laser or non-laser LEDs attached radially in an inwardly-facing manner to a flexible, Inflatable ring; a one-way valve; flexible two-track contact points; a power cord attached to either of the two tracks, and at the other end, a containment compartment in which are enclosed a battery, signal-receiver for activation, as well as other standard electronic components such as resistars and battery contacts. 
         [0016]    The invention is to be implanted in a major vein, by-way of catheter, within a person afflicted with blood-associated cancer or viral infection to afford interaction of light, laser or non-laser, with psoralens or light sensitivity enhancing chemicals, or through energy-produced vibrations produced by a low-power violet excitation laser designed to pulsate every one hundred quadrillionths of a second, with laser density of  5  microjoules per square centimeter. This low density laser light is such that human cells within close proximity of viral cells would remain undamaged. 
     
    
     
       BRIEF DESCRIPTION OF DRAWINGS 
         [0017]    The drawings constitute a part of this specification and include exemplary embodiments to the invention, as well as examples of intravenous insertion. It should be understood that in some instances, various aspects of the invention, its components, and the processes of insertion may be miniaturized or enlarged to facilitate an understanding of the invention. Various subtle modifications may be required to accommodate the vein insertion in a child. 
           [0018]      FIG. 1  Gives an inventory of entire required components to affect begin-to-end process. 
           [0019]      FIG. 2  Shows a section view of the circular LED implant, air bleed-valve, and the circuit containment compartment and its contents. 
           [0020]      FIG. 3  Shows all components, assembled, in cut-away form. 
           [0021]      FIG. 4  Is the circular LED implant, connected to the closed containment compartment by a 2-strand cord. 
           [0022]      FIG. 5  Shows flexible contact tracks and inside plastic layer with holes to accommodate LEDs, and the 2-strand cord attached to ends of the tracks. 
           [0023]      FIG. 6  Shows contact tracks and an adhesive utilized to adhere tracks to the inner surface of the inside plastic layer, and liquid solder to affix the LEDs to each of the 2 tracks. Adhesive around the holes secure LEDs to inner circumference of hole. 
           [0024]      FIG. 7  Shows fully assembled circuit of ten LEDs, and triple plastic layers heat-sealed at the bottom edges. Saline feed valve is in place. 
           [0025]      FIG. 8  Shows all three layers of the LED circle, separate, and a view of all three, heat-sealed at their bottom edges. 
           [0026]      FIG. 9  Shows the two layers of plastic designed to eventually contain saline, and the one-way saline injection valve, dismantled, and then assembled. 
           [0027]      FIG. 10  Shows a heat sealing process of plastic layers. 
           [0028]      FIG. 11  Is a view of the inflated circle of LEDs, from below. 
           [0029]      FIG. 12  Is a partially sectioned view of the circle showing inner LEDs, track, saline valve and cord. 
           [0030]      FIG. 13  Shows a sectioned view of saline containment area, LEDs, tracks, valve and cord. 
           [0031]      FIG. 14  Expresses the concept of a circle of LEDs, radiating light radially. 
           [0032]      FIG. 15  Shows flexible catheter and saline injector barrel. 
           [0033]      FIG. 16  Shows threaded end of the injector barrel being attached to the syringe. 
           [0034]      FIG. 17  Shows injector barrel&#39;s needle submerged in saline as plunger draws saline into the syringe. 
           [0035]      FIG. 18  Shows the end of the saline feed barrel feeding up into the end of the catheter, and the cord being fed into the capsule end of the catheter. 
           [0036]      FIG. 19  Shows deflated circle of LEDs being rolled into “package”, and the air bleed-valve designed to be inserted into valve to allow evacuation of entrapped air to afford smallest possible “package”. 
           [0037]      FIG. 20  Shows tightly rolled “package” with saline-filled feed barrel ready for attachment to valve. 
           [0038]      FIG. 21  Shows multiple views and section views of valve and threaded injector barrel, with hollow needle. 
           [0039]      FIG. 22  Shows cross-section view of deflated LED circle, and injector barrel and needle in place for threaded attachment. 
           [0040]      FIG. 23  Shows injector barrel attached to valve, readying “package” to be drawn down into the capsule by pulling on the syringe at the opposite end of the catheter. 
           [0041]      FIG. 24  Is an aerial view of the LED “package”, fully submerged down into the capsule. 
           [0042]      FIG. 25  Shows insertion of the capsule and of the catheter into the incision on the inner-thigh of the recipient, and on into the common iliac vein. 
           [0043]      FIG. 26  Shows catheter positioned at desired location, sectioned to show content of catheter, with arrow to indicate direction of saline feed barrel when “package” is pushed from capsule to vein. 
           [0044]      FIG. 27  Shows “package” exiting capsule and entering vein. 
           [0045]      FIG. 28  Shows “package” completely freed from capsule and ready for inflation process. 
           [0046]      FIG. 29  Shows ultrasound device and visual monitor utilized in ultrasonography to track insertion and inflation of LED circle. 
           [0047]      FIG. 30  Shows section views of saline containment area and valve and injector barrel as plunger forces saline from the syringe and up into the circle of LEDs. 
           [0048]      FIG. 31  Shows the LED circle as it fills with saline and fills the inner-perimeter of the vein. 
           [0049]      FIG. 32  Shows entire process of saline injection/inflation of LED circle in the common iliac vein of the recipient. 
           [0050]      FIG. 33  Shows fully inflated LED circle, burrs set in vein, and an arrow to indicate disconnection of injector barrel from valve by turning opposite end of barrel. 
           [0051]      FIG. 34  Shows disconnected injector barrel as barrel and catheter now are pulled down and out of the vein. 
           [0052]      FIG. 35  Shows injector barrel and catheter removed, leaving LED circle secured stationary by multiple burrs, and 2-strand cord leading from LED circle to vein and thigh incisions. 
           [0053]      FIG. 36  Shows 2-strand cord protruding from vein, now sutured closed, and the ends of the cord separated and ends cleared of insulation. 
           [0054]      FIG. 37  Shows cleared copper wire at the ends of the cord being secured by a screwdriver to the contact points inside the circuit containment compartment. 
           [0055]      FIG. 38  Shows ends of cord fully attached to contact points making containment compartment ready for closing and sealing. 
           [0056]      FIG. 39  Shows the closed and sealed circuit containment compartment being inserted beneath the skin of the inner-thigh of the recipient. 
           [0057]      FIG. 40  Shows insertion process, in its completion, with section views of LED circle with arrow to indicate direction of circulated blood through the circle of LEDs, the implanted circuit containment compartment, sutured incision on inner-thigh, and remote-control which now activates the LEDs intended to affect irradiation of malign cells, integrated with blood components circulating through the radiated light. 
           [0058]      FIG. 41  Is a schematic of a typical drive circuit designed to maintain a precise, non-fluxuating source of constant energy to safely power the circle of LEDs. 
           [0059]      FIG. 42  Shows close-up view of circle of LEDs with an arrow to indicate direction of circulating blood. 
           [0060]      FIG. 43  Shows a section view of the circle of LEDs, its saline containment area, and small burr that facilitates stationary stability. 
           [0061]      FIG. 44  Is an aerial view of the circle of LEDs, with arrows indicating radial irradiation of light into circulating blood in a human blood vein. 
       
    
    
     DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 
       [0062]    Detailed descriptions of the preferred embodiments are provided herein. It should be understood, however, that the present invention may undergo changes in size and form to accommodate a smaller circumference or location of a selected vein. Specific details disclosed herein are not to be interpreted as limiting, but rather as a basis for the claims and as a representative basis for instructing one skilled in intravenous, catheter-deployed medical devices. (See  FIGS. 45-48  for examples of alternative design.) 
         [0063]      FIG. 1  shows a complete inventory of apparatus and necessities to affect the process of intravenous implantation of the invention  100 .  FIG. 4  shows circle  26  of LEDs  20 , cord  22 , and the circuit containment compartment  31 , which are all that will remain implanted. 
         [0064]    Invention&#39;s  100  saline  28  filled circle  26  of LEDs  20 , as shown in sectioned view in  FIG. 2 , is comprised of two contact tracks  21 , to which multiple of LEDs  20  are attached radially, as also shown in  FIGS. 11 and 14 , facing inwardly toward the center of the circle  26 . 
         [0065]      FIG. 6  shows the inner-sheet  29  of plastic to which the two flexible tracks  21  are affixed with an adhesive  58 . LEDs  20  are then positioned into pre-cut holes  56 , with adhesive  58 , and affixed to the tracks  21  with a liquid solder  59 . Tracks  21  are electrically conductant, thin, and flexible, as also indicated in  FIG. 6 . 
         [0066]    A two-strand cord  22  is connected with liquid solder  59  to the end of each track  21 , then inserted into a small hole  57  where the cord  22  protrudes out the same side as the faces of the LEDs  20 , as shown in  FIGS. 5 ,  7  and  8 . 
         [0067]      FIG. 8  shows two more separate layers of plastic  27   a  and  27   b,  that will eventually be joined to create a saline  28  containment area  27 , as shown in  FIGS. 30 and 43 . 
         [0068]    Bottom ends of the three layers of plastic  27   a,    27   b  and  29  are heat-sealed  63  at their bottom edges as shown in  FIGS. 7 and 10 , with burrs  25  facing outward on the circle&#39;s  26  surface, and positioned before heat-sealing  63  to where the valve  23  insertion hole  60  remains in line, as shown in  FIG. 9-I , and  FIG. 7-II .  FIG. 10  shows several actual heat-sealing  63  processes. 
         [0069]    Soft plastic layer  27   b,  which will ultimately become the outwardly-facing surface of the circle  26 , has multiple burrs  25  running lengthwise and at the center of its surface, as shown in  FIGS. 11 and 12 . These plastic burrs  25  will provide stationary stability for the circle  26  of LEDs  20 , once it has been inflated in a vein  36 , as shown in  FIGS. 33 and 34 . 
         [0070]    With soft plastic layers  27   a,    27   b  and  29  heat-sealed along their bottom edges, the valve  23  hole  60  will be perfectly round and sized to afford a snug, airtight fit when the valve  23  is pressed into the hole  60  from beneath. A coating of adhesive sealer  64  precedes placement of the valve&#39;s  23  securing ring which holds the valve  23  in position, and creates an airtight, leak-proof seal, as shown in  FIG. 9-I , II and III, and  FIG. 7-I  and II. 
         [0071]    With valve  23  positioned, the top edges of soft plastic layers  27   a  and  29  are the heat-sealed  63 , as shown in  FIG. 10-I . Once heat-sealing  63  is affected, both ends of all three layers are folded until opposite ends meet, as shown in  FIG. 10-II . The ends of layers  27   a  and  29  are then heat-sealed  63  together to create a circle  26 , with LEDs  20  facing inwardly toward the center of the circle  26 , as shown in  FIG. 10-II ,  FIG. 11 , and  FIG. 44 . 
         [0072]    The outside layer  27   b,  with outwardly-facing burrs  25 , has a slightly longer length than layers  27   a  and  29 . Separate ends of layer  27   b  are heat-sealed  63  together as shown in  FIG. 10-III , creating a constantly running space between layers  27   a  and  27   b.  This “space” will become the saline  28  containment area  27  once the edges of all three layers are heat-sealed. 
         [0073]    With all bottom and end edges now heat-sealed  63 , the top edges of layers  29  and  27   a  are then sealed  63 , creating an airtight enclosure for tracks  21  and LED  20  and cord  22  contact points. At this point the top edge of layer  27   b  is carefully heat-sealed  63  along the heat-sealed  63  seam at the top of layers  27   a  and  29 . 
         [0074]      FIGS. 22 and 30  show section views where heat-sealing  63  has been affected to create what has now become the saline  28  containment area  27 . It is into this area  27  or space that saline  28  will be injected through the one-way valve  23  as it passes through the feed tube  40  under pressure from pressing the plunger  45 , forcing saline  28  from the syringe. Circle  26  of LEDs  20  is now assembled. 
         [0075]    At the opposite end of the two-strand cord  22 , as shown in  FIG. 2 , is a circular hard plastic circuit containment compartment  31 . This compartment  31  contains two contact screws  48 , a battery  32  and battery bracket  50 , a signal receiver  47  for a remote-control  46 , and an assortment of resistors  55 . Combined, this circuit provides a constant, non-fluxuating energy source which activates the multiple LEDs  20  within the light-radiating circle  26  at the opposite end of the two-strand cord  22 , when the “ON” button  53  of the remote-control  46  is pressed. 
         [0076]    Utilizing invention  100  as an intravenous light “filter” to destroy the replicative values of viruses or cancerous cells requires a procedure of surgery that necessitates the use of a syringe  44 , a catheter  38  with capsule  39  end, a saline  28  feed tube  40  with threaded end  42  that corresponds with the threaded mouth  65  of the syringe  44 , and a threaded cap  41  at the feed tube&#39;s  40  opposite end with a blunt, hollow needle  45  at its center designed to be threaded onto and inserted into the LED  20  circle&#39;s  26  one-way valve  23 . A container of saline  28  is required, as is an air bleed-valve  24  that allows for a total collapse of the saline  28  containment area  27 , so the rolling and folding of the LED  20  circle  26  into a small enough “package” to fit down into the capsule  39  end of the catheter  38  can be adequately affected before intravenous insertion may begin. The circuit containment compartment  31  is the last component of the procedure. 
         [0077]    To begin the assembly of insertion components, the threaded end  42  of the saline  28  feed tube  40  is threaded down onto the threaded mouth  65  of the syringe  44 , as shown in  FIG. 16 . 
         [0078]      FIG. 17  shows the end of the feed tube  40 , submerged into a bottle of saline  28 . As plunger  45  of the syringe  44  is pulled down, as indicated by arrow, saline  28  is drawn through the blunt needle  43 , through the feed tube  40 , and into the syringe  44 . 
         [0079]    Once syringe  44  is filled with saline  28 , the insertion catheter  38  must be prepared. As shown in  FIG. 18 , the two-strand cord  22  is fed down into the capsule  39  end of the catheter. When cord  22  has protruded from the opposite end of the catheter  38 , the end of the feed tube  40  with blunt needle  43  at its center is fed into the bottom end of the catheter  38  while cord  22  is held in place. 
         [0080]      FIG. 19  shows cord  22  and feed tube positioned inside catheter  38 . Air bleed-valve  24  must now be inserted in saline  28  conduit valve  23  to allow trapped air to evacuate from the saline  28  containment area  27  of the circle  26  of LEDs to allow “package” to be rolled, as larger curved arrow indicates, into its most compact state. 
         [0081]    As shown in  FIG. 20 , once the circle  26  of LEDs  20  has been affectively rolled into its most compact state, plunger  45  of syringe  44  is pressed to insure feed tube  40  is filled to the tip of its blunt needle  43  with saline  28 . When verification of filled feed tube  40  is complete, threaded end  41  and blunt needle  43  are aligned with the threaded valve&#39;s  21  mouth. The syringe  44  at the opposite end of the catheter  40 , as seen in  FIG. 32 , is turned clockwise as indicated by spiraling arrow in  FIGS. 20 ,  21  and  22 .  FIG. 23  shows threaded end  41  firmly attached to the valve  23 . Arrow indicates “package” is ready to be pulled down into the catheter&#39;s  38  capsule  39  by-way of pulling the syringe  44  at the opposite end of the catheter  38 . 
         [0082]      FIG. 24-I  shows an aerial view of “package” recessed down into the capsule  39 .  FIG. 24-II  shows a partial section view of the top edge of the folded circle  26  of LEDs  20 , now ready for insertion into a recipient&#39;s thigh  34  incision  35 , and on into the selected vein  36 . 
         [0083]    It should be noted that the insertion process utilizes a method of tracking the depth, direction and eventual deployment of the circle  26  of LEDs  20  inside the selected vein  36 , called ultrasonography. An ultrasound device  61 , as shown in  FIG. 29  relays images to a monitor which allows for an accurate, precise positioning and placement of the intravenous implant. 
         [0084]      FIG. 26  shows a section view of the catheter  38 , its capsule  39 , and the “package”, cord  22  and feed tube  40 , in position in the recipient&#39;s common iliac vein  36 . Arrows indicate direction of movement up into the vein  36 . 
         [0085]      FIG. 27  shows “package” exiting capsule  39  as syringe  44  at the opposite end is pressed into the catheter  38 . 
         [0086]      FIG. 28  shows “package” now fully in view as shown on the monitor in  FIG. 29 . The process of inflating the saline  28  containment areas  27  may now proceed. 
         [0087]      FIG. 30  shows cut-away views of saline  28  leaving the open end of the blunt needle  43 , filling the saline  28  containment area  27 , as the plunger  45  is pressed, as the wide arrow indicates, forcing saline  28  from the syringe  44 , as the narrow arrow indicates, through the saline  28  feed tube  40 , and into the containment area  27 . 
         [0088]      FIG. 31  shows the circle  26  of LEDs  20  inflating and taking on its circular shape. Note the burrs  25  encircling the center of the outer surface of the circle  26 . 
         [0089]      FIG. 32  shows the entire assembly of syringe  44 , feed tube  40 , and catheter  38 . Circle  26  of LEDs  20  is fully inflated. Arrow again indicates plunger  45  pressing saline  28  into the containment area  27 . 
         [0090]      FIG. 33  shows circle  26  fully inflated. Burrs  25  have now indented into the inner-surface of the vein  36  where they will serve to cause the circle  26  to remain stable and stationary. The feed tube  40  is now disconnected from the valve  23  by turning syringe  44  at the opposite end of the catheter  38 . As feed tube  40  is removed, tiny rubber flaps  66 , as shown in  FIG. 21-IV , are pressed closed by the pressure of the saline  28  entrapped within the containment area  27 , serving to “trap” saline inside the area  27 . 
         [0091]      FIG. 34  shows feed tube  40  disconnected from the valve  23 . Catheter  38  and feed tube  40  are now pulled down and extracted from recipients vein  36 , then out through the incision  35  on the inner-thigh  34 . Incision  37  in the common iliac vein is now sutured  52  or “lased” tightly around protruding cord  22 , as shown in  FIG. 36 . Insulation is trimmed from the end of both strands, after strands are separated, to expose copper wire  67 . 
         [0092]      FIG. 37  shows copper wire  67  at the ends of the separated strands of the cord  22  as they are securely attached to contact points  48 . Screws In contacts  48  are tightened with a screw driver  62 , as arrow indicates. 
         [0093]      FIG. 38  shows both strands of the cord  22  attached to the contacts  48 , completing the circuit housed within the containment compartment  31 . The compartment  31  may now be closed at its hinge  33 . Soft rubber seals  30  seal area around the cord  22  where it exits the compartment  31 . Compartment  31  is sealed shut with non-toxic adhesive and made ready for concealment beneath the skin of the inner-thigh  34 . 
         [0094]      FIG. 39  shows containment compartment  31  as it is being inserted through the incision  35  on the inner-thigh  34 . 
         [0095]    With compartment  31  insertion process complete, and incision  35  on the inner-thigh  34  is sutured  51  closed, the “ON” button  53  on the remote-control  46  is pressed to activate the radially-positioned LEDs  20  that line the inside of the circle  26 . Arrow in cut-away view shows the direction of blood-flow through the circle&#39;s  26  light. Circle  26 , cord  22  and containment compartment  31  are the “invention”  100  that remains implanted. 
         [0096]      FIG. 41  shows a schematic  54  of a constant power circuit, designed to safeguard the LEDs  20  from an increased electrical energy that could accidentally increase intensity of laser or non-laser light radiated from the selected LEDs  20  to combat a specific targeted virus or cancerous infestation. 
         [0097]      FIG. 42  shows activated LEDs  20 . Arrow indicates the direction of circulated blood. 
         [0098]      FIG. 43  shows a section view of the circle of LEDs  20  and its saline  28  containment area  27 . Arrow indicates the direction of circulated blood. 
         [0099]      FIG. 44  shows an aerial view of a cross-section of the vein  36 , looking down into the circle  26  of LEDs  20 . Arrows indicate the direction of irradiated laser or non-laser light, radiating into circulating blood, from total-surface light-emitting diodes  20 . 
       Alternative Embodiments 
       [0100]    As stated on page  14  of this application under the heading of “Detailed Description of Preferred Embodiments”, in paragraph one, specific details in  FIGS. 1-44  are not to be interpreted as limiting, but rather as a basis for the claims. 
         [0101]    The following  FIGS. 45-48  are intended to establish an alternative design where light-emitting diodes and contact tracks are housed within an injector molded body, fabricated of a non-toxic, flexible, collapsible material, such as nylon. Flat-faced LEDs replace conventional round-faced ones intended to alleviate the necessity of blood thinning agents used to reduce coagulation. 
         [0102]    Primary claims regarding photodynamics, phototherapy and utilization of psoralens and fetosecond laser light vibrative energy remain as on pages  24 ,  25 , and  26  herein. 
       Brief Description of FIG. 45-48 
       [0103]      FIG. 45  Shows two components that comprise insertion implements to affect deployment of the molded nylon body encasing flat-faced LEDs and contact tracks. 
         [0104]      FIG. 46  Shows the two components comprising insertion implements, assembled. 
         [0105]      FIG. 47  Shows a 3-step process of inserting the collapsible, nylon-housed circle of LEDs in preparation for deployment into a human blood vessel. 
         [0106]      FIG. 48  Shows I, an aerial view of flat-faced LEDs, contact tracks and cord; II, an underside view of a flat-faced LED attached to contact tracks with cord; III, an assembled circle of LEDs, attached to tracks and cord, positioned for injector molding; IV, injector molding process completed leaving LEDs, tracks and cord contacts housed within a sealed, nylon body; V, a view looking down into the nylon encased circle of LEDs, tracks and cord, and VI, a common No. 2 pencil pressing the collapsible circle to show the circle&#39;s flexibility. Pencil provides perspective of approximate circumference of circle. 
       Numbered Components of FIGS. 45-48 
       [0000]    
       
           20   b:  Flat-faced LEDs 
           21   b:  Contact tracks 
           25   b:  Burs 
           26   b:  Nylon circle 
           38   b:  Catheter 
           40   b:  Guide rod 
           66 : Retracting metal 
           68 : Textured grip, with inner-threading to correspond with threaded guide rod 
           69 : Plastic injector mold 
           70 : No. 2 pencil